160 related articles for article (PubMed ID: 11927138)
1. Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol.
Yamashita H; Morinobu S; Yamawaki S; Horiguchi J; Nagao M
Psychiatry Res; 2002 Mar; 109(2):137-42. PubMed ID: 11927138
[TBL] [Abstract][Full Text] [Related]
2. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.
Potkin SG; Thyrum PT; Alva G; Bera R; Yeh C; Arvanitis LA
J Clin Psychopharmacol; 2002 Apr; 22(2):121-30. PubMed ID: 11910256
[TBL] [Abstract][Full Text] [Related]
3. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
Citrome L; Jaffe A; Levine J
Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients.
Blin O; Azorin JM; Bouhours P
J Clin Psychopharmacol; 1996 Feb; 16(1):38-44. PubMed ID: 8834417
[TBL] [Abstract][Full Text] [Related]
5. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
6. Quality of life of schizophrenic patients treated with haloperidol depot and injection preparation of long-lasting risperidone.
Mihajlović G; Jovanović-Mihajlović N; Radmanović B; Radonjić K; Djukić-Dejanović S; Janković S; Janjić V; Milovanović N; Petrović D; Tomić K
Srp Arh Celok Lek; 2011 Dec; 139 Suppl 1():36-40. PubMed ID: 22352201
[TBL] [Abstract][Full Text] [Related]
7. Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients.
Czobor P; Volavka J
J Clin Psychopharmacol; 1993 Oct; 13(5):332-42. PubMed ID: 7693770
[TBL] [Abstract][Full Text] [Related]
8. Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.
Artaloytia JF; Arango C; Lahti A; Sanz J; Pascual A; Cubero P; Prieto D; Palomo T
Am J Psychiatry; 2006 Mar; 163(3):488-93. PubMed ID: 16513871
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Tada M; Shirakawa K; Matsuoka N; Mutoh S
Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study.
Alptekin K; Hafez J; Brook S; Akkaya C; Tzebelikos E; Ucok A; El Tallawy H; Danaci AE; Lowe W; Karayal ON
Int Clin Psychopharmacol; 2009 Sep; 24(5):229-38. PubMed ID: 19531959
[TBL] [Abstract][Full Text] [Related]
11. Risperidone in the treatment of schizophrenia.
Marder SR; Meibach RC
Am J Psychiatry; 1994 Jun; 151(6):825-35. PubMed ID: 7514366
[TBL] [Abstract][Full Text] [Related]
12. Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group.
Peuskens J
Br J Psychiatry; 1995 Jun; 166(6):712-26; discussion 727-33. PubMed ID: 7545060
[TBL] [Abstract][Full Text] [Related]
13. Risperidone: neurochemical, pharmacologic and clinical properties of a new antipsychotic drug.
Keegan D
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S46-52. PubMed ID: 7533051
[TBL] [Abstract][Full Text] [Related]
14. The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs.
Wetter TC; Lauer CJ; Gillich G; Pollmächer T
J Psychiatr Res; 1996; 30(6):411-9. PubMed ID: 9023785
[TBL] [Abstract][Full Text] [Related]
15. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W
J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of risperidone.
Ereshefsky L; Lacombe S
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S80-8. PubMed ID: 7504573
[TBL] [Abstract][Full Text] [Related]
17. Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study.
Claus A; Bollen J; De Cuyper H; Eneman M; Malfroid M; Peuskens J; Heylen S
Acta Psychiatr Scand; 1992 Apr; 85(4):295-305. PubMed ID: 1375801
[TBL] [Abstract][Full Text] [Related]
18. Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine.
Walther S; Moggi F; Horn H; Moskvitin K; Abderhalden C; Maier N; Strik W; Müller TJ
J Clin Psychopharmacol; 2014 Feb; 34(1):124-8. PubMed ID: 24346752
[TBL] [Abstract][Full Text] [Related]
19. Influence of aging on the improvement of subjective sleep quality by atypical antipsychotic drugs in patients with schizophrenia: comparison of middle-aged and older adults.
Yamashita H; Mori K; Nagao M; Okamoto Y; Morinobu S; Yamawaki S
Am J Geriatr Psychiatry; 2005 May; 13(5):377-84. PubMed ID: 15879586
[TBL] [Abstract][Full Text] [Related]
20. Minimum effective doses of haloperidol for the treatment of first psychotic episode: a comparative study with risperidone and olanzapine.
Apiquian R; Fresán A; Herrera K; Ulloa RE; Lóyzaga C; de la Fuente-Sandoval C; Gutiérrez D; Nicolini H
Int J Neuropsychopharmacol; 2003 Dec; 6(4):403-8. PubMed ID: 14604455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]